Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (161-170 of 518) with videos related to

Pageof 52
Sort By:
Psychiatry and Clinical Neurosciences|September 5, 2019
Increased plasma levels of 8-oxoguanine DNA glycosylase-1 in bipolar disorderDeniz Ceylan, Selda Yılmaz, Uğur Bora, et al.
Molecular Neuropsychiatry|May 14, 2020
EAAT2 as a Research Target in Bipolar Disorder and Unipolar Depression: A Systematic ReviewCaren J Blacker, Vincent Millischer, Lauren M Webb, et al.
Journal of Clinical Psychopharmacology|September 26, 2025
Diet Drug Interactions: Achieving and Maintaining Ketosis As Adjunct to Psychotropic PolypharmacotherapyDina N Ali, Mark A Frye, Iain H Campbell, et al.
Journal of Psychiatry & Neuroscience : JPN|October 16, 2004
Peripheral thyroid hormones and response to selective serotonin reuptake inhibitorsMichael Gitlin, Lori L Altshuler, Mark A Frye, et al.
Therapeutic Advances in Psychopharmacology|November 17, 2025
Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysisAhmed Elmosalamy, Idil Tarikogullari, Liliana Patarroyo-Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Odor tracking in flying <i>Drosophila</i> requires visual reafference and compass neuronsJohn Paul Currea, Ava E Bignell, Isabelle Rieke-Wey, et al.
Psychosomatics|December 5, 2012
Hypovitaminosis D in psychiatric inpatients: clinical correlation with depressive symptoms, cognitive impairment, and prescribing practicesDavid D Leedahl, Julie L Cunningham, Matthew T Drake, et al.
Bipolar Disorders|May 1, 2024
Measuring the exposome in bipolar disorderMete Ercis, Aysegul Ozerdem, Marin Veldic, et al.
Therapeutic Advances in Psychopharmacology|February 24, 2026
Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney diseaseBalwinder Singh, Maria L Gonzalez Suarez, Ritika Baweja, et al.
Journal of Affective Disorders|October 10, 2024
Delays in bipolar depression treatment in primary care vs. integrated behavioral health and specialty careJin Hong Park, Scott A Breitinger, Samuel T Savitz, et al.
Pageof 52

Showing results (161-170 of 518) with videos related to

Sort By:
Pageof 52
Psychiatry and Clinical Neurosciences|September 5, 2019
Increased plasma levels of 8-oxoguanine DNA glycosylase-1 in bipolar disorderDeniz Ceylan, Selda Yılmaz, Uğur Bora, et al.
Molecular Neuropsychiatry|May 14, 2020
EAAT2 as a Research Target in Bipolar Disorder and Unipolar Depression: A Systematic ReviewCaren J Blacker, Vincent Millischer, Lauren M Webb, et al.
Journal of Clinical Psychopharmacology|September 26, 2025
Diet Drug Interactions: Achieving and Maintaining Ketosis As Adjunct to Psychotropic PolypharmacotherapyDina N Ali, Mark A Frye, Iain H Campbell, et al.
Journal of Psychiatry & Neuroscience : JPN|October 16, 2004
Peripheral thyroid hormones and response to selective serotonin reuptake inhibitorsMichael Gitlin, Lori L Altshuler, Mark A Frye, et al.
Therapeutic Advances in Psychopharmacology|November 17, 2025
Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysisAhmed Elmosalamy, Idil Tarikogullari, Liliana Patarroyo-Rodriguez, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Odor tracking in flying <i>Drosophila</i> requires visual reafference and compass neuronsJohn Paul Currea, Ava E Bignell, Isabelle Rieke-Wey, et al.
Psychosomatics|December 5, 2012
Hypovitaminosis D in psychiatric inpatients: clinical correlation with depressive symptoms, cognitive impairment, and prescribing practicesDavid D Leedahl, Julie L Cunningham, Matthew T Drake, et al.
Bipolar Disorders|May 1, 2024
Measuring the exposome in bipolar disorderMete Ercis, Aysegul Ozerdem, Marin Veldic, et al.
Therapeutic Advances in Psychopharmacology|February 24, 2026
Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney diseaseBalwinder Singh, Maria L Gonzalez Suarez, Ritika Baweja, et al.
Journal of Affective Disorders|October 10, 2024
Delays in bipolar depression treatment in primary care vs. integrated behavioral health and specialty careJin Hong Park, Scott A Breitinger, Samuel T Savitz, et al.
Pageof 52